[ad_1]
CytoDyn's leromlimab, an HIV drug, takes a big step forward Proactive Investors UK
Nader Pourhbadan, CEO of CytoDyn Inc. (OTCQB: CYDY), tells Proactive Investors that Vancouver-based biotech (Washington) has filed the first of its three …
[ad_2]Source link
